Pieris Pharmaceuticals Inc (OQ:PIRS)

Business Focus: Bio Therapeutic Drugs

Recent Price for PIRS
USD 5.280 +0.010 (+0.190%)
NASDAQ Delayed 15 minutes
Oct 17 Close
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
5.480 6.580 N/A 447,339 233.95
1-Day Low 52-Week Low Yield Avg. Volume  
5.250 1.300 0.0% 385,232  

Latest 10 SEC filings (by transaction date) for PIRS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Aug 17/17 Aug 17/17 Geraghty James A Direct Ownership Common Stock P - Open market or private purchase 10,000 $4.82
Aug 17/17 Aug 17/17 Reine Allan Direct Ownership Common Stock P - Open market or private purchase 20,000 $4.89
Aug 17/17 Aug 16/17 Reine Allan Direct Ownership Common Stock P - Open market or private purchase 45,000 $4.79
Aug 11/17 Aug 9/17 Reine Allan Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 450,000  
Jul 27/17 Jul 25/17 Khuong Chau Quang Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 5,018  
Jul 27/17 Jul 25/17 Richman Michael Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 3,288  
May 24/17 May 22/17 Geraghty James A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 30,000  
Apr 27/17 Apr 25/17 Khuong Chau Quang Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,546  
Apr 27/17 Apr 25/17 Richman Michael Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 7,821  
May 9/17 Apr 21/17 Kiritsy Christopher P Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -5,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for PIRS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Aug 17/17 Aug 17/17 Geraghty James A Direct Ownership Common Stock P - Open market or private purchase 10,000 $4.82
Aug 17/17 Aug 17/17 Reine Allan Direct Ownership Common Stock P - Open market or private purchase 20,000 $4.89
Aug 17/17 Aug 16/17 Reine Allan Direct Ownership Common Stock P - Open market or private purchase 45,000 $4.79
Aug 11/17 Aug 9/17 Reine Allan Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 450,000  
Jul 27/17 Jul 25/17 Khuong Chau Quang Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 5,018  
Jul 27/17 Jul 25/17 Richman Michael Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 3,288  
May 24/17 May 22/17 Geraghty James A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 30,000  
May 9/17 Apr 21/17 Kiritsy Christopher P Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -5,000  
May 9/17 Apr 21/17 Kiritsy Christopher P Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 5,000 $1.59
Apr 27/17 Apr 25/17 Khuong Chau Quang Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,546  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Share an Idea with Easy Blurb
140

Twitter

Search (past week) for $PIRS

StockTwits